MECHANISMS OF KUPFFER CELL CYTOTOXICITY IN-VITRO AGAINST THE SYNGENEIC MURINE COLON ADENOCARCINOMA LINE MCA26

被引:33
作者
CURLEY, SA
ROH, MS
FEIG, B
OYEDEJI, C
KLEINERMAN, ES
KLOSTERGAARD, J
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CELL BIOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030
关键词
KUPFFER CELLS; INTERLEUKIN-1; TUMOR NECROSIS FACTOR; L-ARGININE; NITRIC OXIDE;
D O I
10.1002/jlb.53.6.715
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously demonstrated that in vivo activation or inhibition of Kupffer cell (KC) cytotoxic function can reduce or enhance, respectively, the hepatic tumor burden in a syngeneic murine colon adenocarcinoma (MCA26) tumor model. In the current study, we have performed in vitro experiments to define the possible mechanisms of KC cytotoxicity against MCA26 cells. Addition of either anti-tumor necrosis factor (TNF) or anti-interleukin-1alpha (IL-1alpha) antisera reduced KC cytotoxicity in coculture against MCA26 targets in a dose-dependent fashion; addition of these sera together resulted in approximately additive inhibition, suggesting the existence of parallel pathways for these effector molecules. Nitric oxide as a mediator of cytotoxicity by KCs in coculture with MCA26 cells was evaluated by two approaches. Activated KCs produced detectable levels of nitric oxide; however, activated KC exerted cytotoxicity against MCA26 targets in the absence of exogenous free L-arginine. Thus, TNF and IL-1 play major roles in producing murine KC cytotoxicity against MCA26 colon cancer cells in vitro, whereas reactive nitric oxides do not.
引用
收藏
页码:715 / 721
页数:7
相关论文
共 42 条
  • [1] AYALA A, 1991, J IMMUNOL, V147, P4147
  • [2] BENGMARK S, 1969, CANCER, V23, P198, DOI 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO
  • [3] 2-J
  • [4] TUMOR NECROSIS FACTOR CACHECTIN INCREASES PERMEABILITY OF ENDOTHELIAL-CELL MONOLAYERS BY A MECHANISM INVOLVING REGULATORY G-PROTEINS
    BRETT, J
    GERLACH, H
    NAWROTH, P
    STEINBERG, S
    GODMAN, G
    STERN, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) : 1977 - 1991
  • [5] CHENSUE SW, 1991, AM J PATHOL, V138, P395
  • [6] CURLEY SA, 1990, SURG FORUM, V41, P438
  • [7] DECKER T, 1987, J IMMUNOL, V138, P957
  • [8] DING AH, 1988, J IMMUNOL, V141, P2407
  • [9] MURINE CYTOTOXIC ACTIVATED MACROPHAGES INHIBIT ACONITASE IN TUMOR-CELLS - INHIBITION INVOLVES THE IRON-SULFUR PROSTHETIC GROUP AND IS REVERSIBLE
    DRAPIER, JC
    HIBBS, JB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03) : 790 - 797
  • [10] FIDLER IJ, 1982, CANCER RES, V42, P496